A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf
.
PROGRANULIN: IS IT A NEW ADIPOCYTOKINE AT THE CROSSROADS OF OBESITY, METABOLIC SYNDROME AND CANCER?
2017
LIFE International Journal of Health and Life-Sciences
Progranulin (PGRN) stimulates the proliferation and survival of several cancer cell types. Obesity increases the risk for metabolic as well as cardiovascular diseases, and is linked to an increased incidence and aggressiveness of various cancers. Prepubertal morbid obese (MO) children and those with metabolic syndrome (MetS) (MO+MetS) were included in our studies. World Health Organization age-and sex-dependent body mass index percentile tables were used for the classification of obesity. MetS
doi:10.20319/lijhls.2017.33.2937
fatcat:ctokwp6x2zcflcjeomuv5zm3vu